Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr 22;131(15):5667-74.
doi: 10.1021/ja900414s.

Gold(I)-catalyzed coupling reactions for the synthesis of diverse small molecules using the build/couple/pair strategy

Affiliations

Gold(I)-catalyzed coupling reactions for the synthesis of diverse small molecules using the build/couple/pair strategy

Tuoping Luo et al. J Am Chem Soc. .

Abstract

The build/couple/pair strategy has yielded small molecules with stereochemical and skeletal diversity by using short reaction sequences. Subsequent screening has shown that these compounds can achieve biological tasks considered challenging if not impossible ('undruggable') for small molecules. We have developed gold(I)-catalyzed cascade reactions of easily prepared propargyl propiolates as a means to achieve effective intermolecular coupling reactions for this strategy. Sequential alkyne activation of propargyl propiolates by a cationic gold(I) catalyst yields an oxocarbenium ion that we previously showed is trapped by C-based nucleophiles at an extrannular site to yield alpha-pyrones. Here, we report O-based nucleophiles react by ring opening to afford a novel polyfunctional product. In addition, by coupling suitable building blocks, we subsequently performed intramolecular pairing reactions that yield diverse and complex skeletons. These pairing reactions include one based on a novel aza-Wittig-6pi-electrocyclization sequence and others based on ring-closing metathesis reactions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gold(I)-catalyzed cascade reactions of propargyl propiolates.
Scheme 1
Scheme 1
Scheme 2
Scheme 2
Scheme 3
Scheme 3
Scheme 4
Scheme 4
Scheme 5
Scheme 5
Scheme 6
Scheme 6
Scheme 7
Scheme 7

Similar articles

Cited by

References

    1. Schreiber S. L. Nat. Chem. Biol. 2005, 1, 64–66. - PubMed
    2. Stockwell B. R. Nature 2004, 432, 846–854. - PMC - PubMed
    1. Tolliday N.; Clemons P. A.; Ferraiolo P.; Koehler A. N.; Lewis T. A.; Li X.; Schreiber S. L.; Gerhard D. S.; Eliasof S. Cancer Res. 2006, 66, 8935–8942. - PubMed
    2. Inglese J.; Johnson R. L.; Simeonov A.; Xia M.; Zheng W.; Austin C. P.; Auld D. S. Nat. Chem. Biol. 2007, 3, 466–479. - PubMed
    3. Fox S.; Farr-Jones S.; Sopchak L.; Boggs A.; Nicely H. W.; Khoury R.; Biros M. J. Biomol. Screen. 2006, 11, 864–869. - PubMed
    1. Payne D. J.; Gwynn M. N.; Holmes D. J.; Pompliano D. L. Nat. Rev. Drug Discov. 2007, 6, 29–40. - PubMed
    1. Nielsen T. E.; Schreiber S. L. Angew. Chem., Int. Ed. 2008, 47, 48–56. - PMC - PubMed
    1. Ng P. Y.; Tang Y.; Knosp W. M.; Stadler S.; Shaw J. T. Angew. Chem., Int. Ed. 2007, 46, 5352–5355. - PubMed

Publication types